Haselmeier Inc. announced the opening of its new office in the Boott Cotton Mills at 126 John Street, Suite 11, Lowell, Ma 01852.
A downtown Lowell landmark and part of the Lowell National Park, the newly restored, historic 19th century textile mill is strategically located 25 miles north of Boston, between Logan International Airport and Manchester Boston Regional Airport. The new location provides easy access for US and international clients, vendors and visitors.
The move stems from Haselmeier’s growth in the last year and will enable Haselmeier to maintain closer contact with its customers. Lowell, MA was chosen for its central location within a growing medical device region and its close proximity to the University of Massachusetts Lowell with its globally recognized engineering programs. Lowell is also home to M2D2, the Massachusetts Medical Device Development Center, a collaboration of State, Private and Academic resources supporting emerging medical technology and device start-ups.
«The relocation offers Haselmeier Inc. access to leading pharmaceutical companies and leading research universities. The new office permits Haselmeier to achieve a greater presence in the medical device industry in the US and offer our US customers a higher level of support» commented Robert Kilgore, President Haselmeier Inc. Terry O’Hagan, Director Business Development added: «Our move to Lowell, MA will accommodate the continued growth of our US business. The space will accommodate increased staff and has been designed to create open, collaborative workspaces for our design teams. Varied meeting and conference spaces will provide our clients with a higher level of service».
Founded in Stuttgart in 1920, Haselmeier is a global medical device company and a leading designer and manufacturer of pen and auto injection systems. The devices feature unique function, design and technology and are marketed by leading pharmaceutical and biotechnology companies around the world.
Located in five locations across three continents, we develop and produce innovative technologies for administering medication to improve the health and everyday life of patients.